Knowledge Centre

Articles

“The alkaloid psilocybin (4-phosphoryloxy-N,N-dimethyltryptamine) and the neurologically active psilocin (4-hydroxy-N,N-dimethyltryptamine) are the foremost compounds of pharmaceutical interest in Psilocybe mushrooms.”

“Data is rarely free. It often has an opportunity (capital or labour) cost associated with its collection; it is an investment and as many have experienced, not all investments work out. “

In this op-ed, Dr. Roggen et al. propose a system for websites like Leafly that would allow its users to share revenue from their content and personal data, enabling a higher sense of trust, credibility and ultimately more value for every stakeholder involved.

“The end-product must be tested for a proper result, and according to Dr. Markus Roggen, the President and CSO of Delic Labs, the end-product for a vape pen is the vapor. To do this, lab tests can ensure that a vape pen will deliver a good dose…”

“Vancouver Delic Corp. and Delic Labs are currently conducting research into psilocybin, or magic mushrooms, which has shown promise as an alternative therapy for various mental health issues…”

“Chemistry is an interesting field as it is concerned with the changes of molecules. Vape pens cause the oil to heat up although it doesn’t always boil or burn. Instead the oil will change…”

White Papers

Fast, Easy, and Reliable Monitoring of THCA and CBDA Decarboxylation in Cannabis Flower and Oil Samples Using Infrared Spectroscopy

Authors:
Sajni Shah, Ali Wasti, and Dr. Markus Roggen; DELIC Labs, Vancouver British Columbia, Canada
Greg Kozadjian, Jean‑Louis Cabral, and Yanqia Wang; Agilent Technologies, Inc.

Crystallization of CBD: Steps for Successfully Scaling Up

Author:
METTLER TOLEDO GROUP

Podcasts

Ask An Expert

Lectures

The Roach Isn’t That Bad

CANN Journal Club 2021

Don’t Be Neutral About Psilocybin Testing

MjBiz Webinar 2021

DELIC Labs uses cookies to
ensure you get the best experience
on our website. View our Privacy
Policy for more information.